Lexicon Pharmaceuticals shares jumped nearly 75% in early trading Friday after the biopharmaceutical company inked a license agreement potentially worth $1 billion with Danish drug maker Novo Nordisk.

Lexicon Pharmaceuticals (LXRX) stock soars as the company inks a licensing deal worth up to $1B with Novo Nordisk (NVO) for ...

Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...

Based on the feedback received, this document may change. Learn about the consultation. Drugs included on the list for exceptional importation and sale are called "designated drugs". They are eligible ...

A urine drug test can quickly detect both illegal and prescription drugs in a person’s system. Doctors, sports officials, and many employers require these tests. Signs of drug use can remain in ...

(Photo Credit: Francis Sheehan/Science Source) The FDA has approved more than 30 antiretroviral drugs to treat HIV infection. They're often broken into nine classes because they work in different ...

Too much of anything can be bad, and the consequence of too much of drugs is something we are all familiar with. Not all of us have tried these drugs, but cinema has shown us the most graphic and ...

A “new black market” for synthetics and drug trafficking through war zones are fuelling instability around the world, the chief of the UN drugs and crime office said on Monday. “Trafficking routes run ...

The Dangerous Drugs Board (DDB) and the Philippine Drug Enforcement Agency (PDEA) are pushing for the amendments of some provisions of the “The Comprehensive dangerous Drugs Act of 2002’’ amid the ...

Years of Experience is the number of years an individual is registered as an investment advisor only, rather than combined years of experience as either an investment advisor or broker.

Drug discovery is extraordinarily difficult. “In 100 years or so of contemporary medicine, we’ve found treatments for only around 500 of the roughly 7,000 rare diseases,” says David Pardoe ...

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...